Daniel Falk

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. doi request reprint Percentage of subjects with no heavy drinking days: evaluation as an efficacy endpoint for alcohol clinical trials
    Daniel Falk
    Division of Treatment and Recovery Research, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland 20892 9304, USA
    Alcohol Clin Exp Res 34:2022-34. 2010

Detail Information

Publications1

  1. doi request reprint Percentage of subjects with no heavy drinking days: evaluation as an efficacy endpoint for alcohol clinical trials
    Daniel Falk
    Division of Treatment and Recovery Research, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland 20892 9304, USA
    Alcohol Clin Exp Res 34:2022-34. 2010
    ..As PSNHDD has been used infrequently in previous alcohol clinical trials, we evaluated the utility and validity of the PSNHDD outcome measure in 2 large alcohol clinical trials...